Kang Michael N, Rizio Louis, Prybicien Michael, Middlemas David A, Blacksin Marcia F
Insall-Scott-Kelly Institute for Orthopedics and Sports Medicine, New York, NY 10021, USA.
J Shoulder Elbow Surg. 2008 Jan-Feb;17(1 Suppl):61S-66S. doi: 10.1016/j.jse.2007.07.010.
Corticosteroids are commonly used in the treatment of the impingement syndrome. Efficacy, as well as accurate placement, have been questioned. The purpose of this prospective, randomized study is to assess the accuracy of subacromial injections and to correlate accuracy with short term clinical outcome at 3 months. Sixty shoulders, which were diagnosed with impingement syndrome, were randomized to receive a subacromial injection of corticosteroids, local anesthetic, and contrast dye from 1 of 3 locations: anterolateral, lateral, or posterior. Accuracy was confirmed by 3 radiographic views of the shoulder, while clinical ratings were assessed by the UCLA shoulder score and a 10-point visual pain analog scale during the initial, post-injection, and 3-month visits. The overall accuracy was 70%, with no difference among the 3 portals. Accuracy was not related to body mass index. Furthermore, accurate injections did not significantly improve the UCLA score, pain scale, or patient satisfaction at 3 months. In contrast, accurate injections produced a positive Neer's impingement test more often (35/39 vs 9/16; P = .009). Overall, there was an improvement in the UCLA score (26.2-32.2; P < .001) and a decrease in the pain scale (7.2-3.43; P < .001) at 3-month follow-up. In conclusion, the accuracy of injection was 70%. Clinical improvement did not correlate with accuracy; however, accuracy did reliably produce a positive impingement test. This multimodal treatment plan did produce significant improvement in shoulder function and pain level in the short term.
皮质类固醇常用于治疗撞击综合征。其疗效以及注射位置的准确性一直受到质疑。这项前瞻性随机研究的目的是评估肩峰下注射的准确性,并将准确性与3个月时的短期临床结果相关联。60例被诊断为撞击综合征的肩部被随机分为3组,分别从前外侧、外侧或后侧3个位置之一接受肩峰下皮质类固醇、局部麻醉剂和造影剂注射。通过肩部的3张X线片确认注射准确性,同时在初次就诊、注射后及3个月随访时,通过加州大学洛杉矶分校(UCLA)肩部评分和10分视觉疼痛模拟量表评估临床评分。总体准确性为70%,3个注射入口之间无差异。准确性与体重指数无关。此外,准确注射在3个月时并未显著改善UCLA评分、疼痛量表评分或患者满意度。相比之下,准确注射更常使Neer撞击试验呈阳性(35/39 vs 9/16;P = 0.009)。总体而言,在3个月随访时,UCLA评分有所改善(26.2 - 32.2;P < 0.001),疼痛量表评分有所下降(7.2 - 3.43;P < 0.001)。总之,注射准确性为70%。临床改善与准确性无关;然而,准确性确实能可靠地使撞击试验呈阳性。这种多模式治疗方案在短期内确实使肩部功能和疼痛程度有了显著改善。